BUY MBP RABIES VACCINE BERIRAB-P 750IU 5ML BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Berirab-P 750 IU is a human rabies immunoglobulin (HRIG) used for post-exposure prophylaxis against rabies following a suspected or confirmed exposure, such as an animal bite, scratch, or contact of saliva with broken skin or mucous membranes. Rabies is almost always fatal once symptoms appear, so prompt treatment is critical.

Berirab-P provides immediate passive immunity by supplying ready-made antibodies that neutralize the rabies virus at the site of entry. This protection is temporary but essential while the body develops its own long-lasting immunity from the rabies vaccine.

Berirab-P is always used together with the rabies vaccine, never alone. The immunoglobulin works immediately, while the vaccine stimulates the body to produce its own antibodies over time.

The recommended dose of Berirab-P is 20 IU per kilogram of body weight. The 750 IU vial allows flexible dosing depending on the patient?s weight. As much of the calculated dose as possible should be infiltrated directly into and around the wound. Any remaining amount should be given intramuscularly at a site far from where the rabies vaccine is injected, usually in a different limb. It must never be mixed in the same syringe or injected at the same site as the vaccine, as this can reduce vaccine effectiveness.

Berirab-P is given only once, preferably at the start of post-exposure treatment (day 0). It should not be repeated, even if vaccine doses continue.

Common side effects include mild pain, redness, swelling, or tenderness at the injection site. Some people may experience mild fever, headache, fatigue, or muscle aches. These effects usually resolve without treatment.

Serious allergic reactions are rare but can occur. Symptoms such as difficulty breathing, swelling of the face or throat, severe dizziness, or rash require immediate medical attention.

Berirab-P is made from carefully screened human plasma and undergoes rigorous viral inactivation steps. The risk of transmitting infections is extremely low.

Berirab-P is considered safe for use in children, pregnant women, and breastfeeding mothers, as the risk from rabies far outweighs any potential risk from the product.

People who have previously completed a full rabies vaccination series usually do not need rabies immunoglobulin again, but only booster vaccine doses, depending on exposure risk.

In summary, Berirab-P 750 IU is a life-saving treatment that provides immediate protection against rabies when given correctly and promptly. Proper wound cleaning, timely immunoglobulin administration, and completion of the rabies vaccination schedule are essential to prevent this fatal disease.